Despite efforts to curb the opioid epidemic, new numbers show the overall rate of opioid prescriptions in the U.S. has not fallen significantly.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more inforrmation visit Asset & Logo Licensing.
Marlene Y. Satter has worked in and written about the financial industry for decades.
By Allison Bell | June 10, 2025
But retention kept HealthEquity's HSA count growing, and the CEO sees cost-cutting pressure increasing employers' interest in new ideas.
By Allison Bell | June 10, 2025
The Employee Benefits Security Administration is rebooting its advice program, as a professional advisor prepares to take over as its chief.
By Alan Goforth | June 09, 2025
“The Guardian knew these accusations were false but published them anyway, brazenly trying to capitalize on the tragic and shocking assassination of UnitedHealthcare’s then-CEO, Brian Thompson, in December 2024,” according to the lawsuit, which was filed on Wednesday in Delaware Superior Court.
White Paper
Sponsored by Noom Health
Benefits Beyond Weight Loss: The Expanding Impact of GLP-1s in Modern Healthcare
GLP-1s are transforming healthcare, but their impact extends far beyond weight loss. For HR leaders, understanding the full scope of benefits and managing costs is crucial. This white paper offers vital insights for your benefits strategy by showing how pairing GLP-1s with support and lifestyle changes is key to cultivating a healthier and happier workforce.
Guide
Sponsored by ArmadaCare
Modern Executive Rewards: Coverage, Comp & Cost Control--All in One
Executive compensation is evolving. Help clients build packages that attract top talent, foster loyalty, and support leader well-being for enhanced productivity. This guide offers key strategies for brokers.
White Paper
Sponsored by Noom Health
Benefits Beyond Weight Loss: The Expanding Impact of GLP-1s in Modern Healthcare
GLP-1s offer health benefits far beyond weight loss, impacting chronic diseases. For brokers, guiding clients on GLP-1 coverage amidst rising costs is key. This white paper provides insights to balance cost and maximize population health.
